98 related articles for article (PubMed ID: 24747077)
1. P-glycoprotein mediates the collateral sensitivity of multidrug resistant cells to steroid hormones.
Laberge RM; Ambadipudi R; Georges E
Biochem Biophys Res Commun; 2014 May; 447(4):574-9. PubMed ID: 24747077
[TBL] [Abstract][Full Text] [Related]
2. A tamoxifen derivative, N,N-diethyl-2-[4-(phenylmethyl) phenoxy] ethanamine, selectively targets P-glycoprotein-positive multidrug resistant Chinese hamster cells.
Georges E; Lian J; Laberge R
Biochem Pharmacol; 2014 Jul; 90(2):107-14. PubMed ID: 24821111
[TBL] [Abstract][Full Text] [Related]
3. Effects of steroids and verapamil on P-glycoprotein ATPase activity: progesterone, desoxycorticosterone, corticosterone and verapamil are mutually non-exclusive modulators.
Orlowski S; Mir LM; Belehradek J; Garrigos M
Biochem J; 1996 Jul; 317 ( Pt 2)(Pt 2):515-22. PubMed ID: 8713080
[TBL] [Abstract][Full Text] [Related]
4. P-glycoprotein (ABCB1) modulates collateral sensitivity of a multidrug resistant cell line to verapamil.
Laberge RM; Ambadipudi R; Georges E
Arch Biochem Biophys; 2009 Nov; 491(1-2):53-60. PubMed ID: 19772851
[TBL] [Abstract][Full Text] [Related]
5. The anti-estrogen receptor drug, tamoxifen, is selectively Lethal to P-glycoprotein-expressing Multidrug resistant tumor cells.
Bakadlag R; Limniatis G; Georges G; Georges E
BMC Cancer; 2023 Jan; 23(1):24. PubMed ID: 36609245
[TBL] [Abstract][Full Text] [Related]
6. A high-throughput screening microplate test for the interaction of drugs with P-glycoprotein.
Garrigues A; Nugier J; Orlowski S; Ezan E
Anal Biochem; 2002 Jun; 305(1):106-14. PubMed ID: 12018951
[TBL] [Abstract][Full Text] [Related]
7. A mechanism for P-glycoprotein-mediated apoptosis as revealed by verapamil hypersensitivity.
Karwatsky J; Lincoln MC; Georges E
Biochemistry; 2003 Oct; 42(42):12163-73. PubMed ID: 14567677
[TBL] [Abstract][Full Text] [Related]
8. Cross-resistance to antitumor diarylsulfonylureas and collateral sensitivity to mitochondrial toxins in a human cell line selected for resistance to the antitumor agent N-(5-indanylsulfonyl)-N'-(4-chlorophenyl)urea.
Sosinski J; Thakar JH; Germain GS; Dias P; Harwood FC; Kuttesch JF; Houghton PJ
Mol Pharmacol; 1994 May; 45(5):962-70. PubMed ID: 7910660
[TBL] [Abstract][Full Text] [Related]
9. Effects of detergents on P-glycoprotein atpase activity: differences in perturbations of basal and verapamil-dependent activities.
Orlowski S; Selosse MA; Boudon C; Micoud C; Mir LM; Belehradek J; Garrigos M
Cancer Biochem Biophys; 1998 Jun; 16(1-2):85-110. PubMed ID: 9923970
[TBL] [Abstract][Full Text] [Related]
10. Competitive and non-competitive inhibition of the multidrug-resistance-associated P-glycoprotein ATPase--further experimental evidence for a multisite model.
Garrigos M; Mir LM; Orlowski S
Eur J Biochem; 1997 Mar; 244(2):664-73. PubMed ID: 9119038
[TBL] [Abstract][Full Text] [Related]
11. Gomisin A alters substrate interaction and reverses P-glycoprotein-mediated multidrug resistance in HepG2-DR cells.
Wan CK; Zhu GY; Shen XL; Chattopadhyay A; Dey S; Fong WF
Biochem Pharmacol; 2006 Sep; 72(7):824-37. PubMed ID: 16889754
[TBL] [Abstract][Full Text] [Related]
12. Bromocriptine modulates P-glycoprotein function.
Orlowski S; Valente D; Garrigos M; Ezan E
Biochem Biophys Res Commun; 1998 Mar; 244(2):481-8. PubMed ID: 9514944
[TBL] [Abstract][Full Text] [Related]
13. Synergistic effect of folate-mediated targeting and verapamil-mediated P-gp inhibition with paclitaxel -polymer micelles to overcome multi-drug resistance.
Wang F; Zhang D; Zhang Q; Chen Y; Zheng D; Hao L; Duan C; Jia L; Liu G; Liu Y
Biomaterials; 2011 Dec; 32(35):9444-56. PubMed ID: 21903258
[TBL] [Abstract][Full Text] [Related]
14. Induction of apoptosis by A3 adenosine receptor agonist N-(3-iodobenzyl)-adenosine-5'-N-methylcarboxamide in human leukaemia cells: a possible involvement of intracellular mechanism.
Mlejnek P; Dolezel P
Acta Physiol (Oxf); 2010 Jun; 199(2):171-9. PubMed ID: 20121715
[TBL] [Abstract][Full Text] [Related]
15. N-ethylmaleimide increases P-glycoprotein photoaffinity labeling with iodoaryl-azidoprazosin in multidrug resistant cells.
Wang Y; Georges E
Anticancer Res; 1997; 17(1A):357-64. PubMed ID: 9066677
[TBL] [Abstract][Full Text] [Related]
16. BIBW22 BS, potent multidrug resistance-reversing agent, binds directly to P-glycoprotein and accumulates in drug-resistant cells.
Liu Z; Lheureux F; Pouliot JF; Heckel A; Bamberger U; Georges E
Mol Pharmacol; 1996 Sep; 50(3):482-92. PubMed ID: 8794885
[TBL] [Abstract][Full Text] [Related]
17. Gain and loss of hypersensitivity to resistance modifiers in multidrug resistant Chinese hamster ovary cells.
Warr JR; Quinn D; Elend M; Fenton JA
Cancer Lett; 1995 Nov; 98(1):115-20. PubMed ID: 8529199
[TBL] [Abstract][Full Text] [Related]
18. Combined treatment of P-gp-positive L1210/VCR cells by verapamil and all-trans retinoic acid induces down-regulation of P-glycoprotein expression and transport activity.
Sulová Z; Macejová D; Seres M; Sedlák J; Brtko J; Breier A
Toxicol In Vitro; 2008 Feb; 22(1):96-105. PubMed ID: 17920233
[TBL] [Abstract][Full Text] [Related]
19. Quantitation of doxorubicin uptake, efflux, and modulation of multidrug resistance (MDR) in MDR human cancer cells.
Shen F; Chu S; Bence AK; Bailey B; Xue X; Erickson PA; Montrose MH; Beck WT; Erickson LC
J Pharmacol Exp Ther; 2008 Jan; 324(1):95-102. PubMed ID: 17947497
[TBL] [Abstract][Full Text] [Related]
20. Multidrug-resistant cancer cells contain two populations of P-glycoprotein with differently stimulated P-gp ATPase activities: evidence from atomic force microscopy and biochemical analysis.
Barakat S; Gayet L; Dayan G; Labialle S; Lazar A; Oleinikov V; Coleman AW; Baggetto LG
Biochem J; 2005 Jun; 388(Pt 2):563-71. PubMed ID: 15693753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
